Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination therapy in rheumatoid arthritis

P M Brooks1

  • 1University of New South Wales, Vincent's Hospital, Darlinghurst, Australia.

Agents and Actions. Supplements
|January 1, 1993
PubMed
Summary

Current rheumatoid arthritis treatments with slow-acting antirheumatic drugs (SAARDs) show limited success. Combination therapies, especially with corticosteroids, may offer benefits, but more research is needed to confirm efficacy and safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Australia needs an Ombudsman or Office for Research Integrity.

Internal medicine journal·2016
Same author

The management of rheumatoid arthritis.

The Australian journal of physiotherapy·2014
Same author

The patient is the teacher: ambulatory patient-centred student-based interprofessional education where the patient is the teacher who improves patient care outcomes.

Internal medicine journal·2013
Same author

The clinical significance of indomethacin-probenecid interaction.

British journal of clinical pharmacology·2012
Same author

The effect of frusemide on indomethacin plasma levels.

British journal of clinical pharmacology·2012
Same author

Over the counter (OTC) oral remedies for arthritis and rheumatism: how effective are they?

Inflammopharmacology·2008

Area of Science:

  • Rheumatology
  • Pharmacology

Background:

  • Rheumatoid arthritis (RA) often leads to severe disability and reduced lifespan.
  • Current slow-acting antirheumatic drugs (SAARDs) achieve few remissions in RA patients.
  • Early SAARD treatment is increasingly adopted to slow erosive disease progression.

Purpose of the Study:

  • To evaluate the efficacy of combination SAARD therapy in rheumatoid arthritis.
  • To assess the benefits of combining SAARDs with corticosteroids for RA management.

Main Methods:

  • Review of existing controlled studies on SAARD combinations.
  • Analysis of studies investigating SAARDs combined with corticosteroids.

Main Results:

  • Few controlled studies demonstrate clear benefits of SAARD combinations over monotherapy.
  • Combinations of SAARDs with corticosteroids show some benefit and reduced side effects.

Conclusions:

  • Further well-designed studies are necessary to confirm the efficacy of SAARD combination therapies in RA patients.
  • Combination therapy, particularly with corticosteroids, warrants further investigation for improved RA outcomes.

Related Experiment Videos